“여탑 ∈ yeotop6.com ∋┎소중히┚상월곡동오피➴상월곡동스파ば상월곡동OP☌상월곡동안마ⅱ상월곡동오피ゅ상월곡동키스방❄상월곡동풀싸롱”的搜索结果，显示 261-270 项，共有 8428 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control by decreasing the number of spinal relapses for ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control by decreasing the number of spinal relapses for ...

3. 外科 - 临床试验- 妙佑医疗国际

   This project will investigate whether ctDNA analysis in newly diagnosed stage I, II, III breast cancer patients treated with neoadjuvant systemic therapy can ...

4. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

5. 神经科- 临床试验- 妙佑医疗国际

   This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study to Develop Liquid Biopsy for ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study to Develop Liquid Biopsy for ...

8. 神经科- 临床试验- 妙佑医疗国际

   This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...

10. 心血管医学- 临床试验- 妙佑医疗国际

    The purpose of this study is to prospectively determine if magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIED) ...